Iluria

Company Overview

Snapshot

Founded in August 2018 by Hagay Levy and Birkat Klimshtein Levy, Iluria operates with 11–50 employees. The company has raised a total of $2.04 million across 5 funding rounds from 2 investors. In May 2022, Iluria secured $460,000 in non-equity funding.

Business overview

Iluria develops a clinically proven software solution for in-depth, continuous, and passive monitoring of ADHD using commercial smart wearables. The company's core technology leverages data analytics, machine learning, and artificial intelligence to detect ADHD-related patterns, aiming to provide personalized and accurate care by shedding light on treatment effectiveness. Iluria serves the healthcare industry, targeting providers, parents, and children, and operates in the Digital Healthcare and Medical Decision Support sectors.

Company Intelligence Q&A

What is Iluria's primary focus?

Iluria focuses on biomarker-based ADHD monitoring through a software solution that utilizes commercial smart wearables for continuous and passive data collection.

When was Iluria founded and by whom?

Iluria was founded in August 2018 by Hagay Levy and Birkat Klimshtein Levy.

Which investor participated in Iluria's December 2020 Pre-Seed round?

In December 2020, Health Wildcatters invested in Iluria's Pre-Seed funding round.

What clinical trials has Iluria completed?

Iluria has completed two successful clinical trials with the Cincinnati Children's Hospital Medical Center and Clalit Health Services.